ATE420106T1 - Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung - Google Patents
Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendungInfo
- Publication number
- ATE420106T1 ATE420106T1 AT99954126T AT99954126T ATE420106T1 AT E420106 T1 ATE420106 T1 AT E420106T1 AT 99954126 T AT99954126 T AT 99954126T AT 99954126 T AT99954126 T AT 99954126T AT E420106 T1 ATE420106 T1 AT E420106T1
- Authority
- AT
- Austria
- Prior art keywords
- code
- dna fragments
- chlamydia
- chlamydia antigen
- strain
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10659098P | 1998-11-02 | 1998-11-02 | |
| US13307199P | 1999-05-07 | 1999-05-07 | |
| US09/430,723 US6607730B1 (en) | 1998-11-02 | 1999-10-29 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420106T1 true ATE420106T1 (de) | 2009-01-15 |
Family
ID=27380151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99954126T ATE420106T1 (de) | 1998-11-02 | 1999-11-02 | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6607730B1 (de) |
| EP (1) | EP1127065B1 (de) |
| JP (1) | JP2002530054A (de) |
| AT (1) | ATE420106T1 (de) |
| AU (1) | AU753984B2 (de) |
| CA (1) | CA2349504A1 (de) |
| DE (1) | DE69940268D1 (de) |
| NZ (1) | NZ511889A (de) |
| WO (1) | WO2000026239A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ512730A (en) * | 1998-12-04 | 2003-12-19 | Univ Manitoba | A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| WO2001013948A1 (en) * | 1999-08-20 | 2001-03-01 | The General Hospital Corporation | Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| ATE463575T1 (de) * | 1999-12-22 | 2010-04-15 | Aventis Pasteur | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
| GB0103169D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1032674B1 (de) | 1997-11-21 | 2007-01-24 | Serono Genetics Institute S.A. | Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung |
| EP2218730A1 (de) | 1997-11-28 | 2010-08-18 | Merck Serono Biodevelopment | Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion |
| AU1722300A (en) | 1998-11-12 | 2000-05-29 | Regents Of The University Of California, The | Chlamydia pneumoniae genome sequence |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| WO2000034483A2 (en) | 1998-12-08 | 2000-06-15 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| US20030095973A1 (en) | 1999-05-03 | 2003-05-22 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| ATE384793T1 (de) | 1999-09-20 | 2008-02-15 | Aventis Pasteur | Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| ATE463575T1 (de) | 1999-12-22 | 2010-04-15 | Aventis Pasteur | Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen |
| ATE389020T1 (de) | 2000-04-21 | 2008-03-15 | Corixa Corp | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
| CA2408199A1 (en) | 2000-05-08 | 2001-11-15 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| EP1297005B1 (de) | 2000-07-03 | 2009-08-26 | Novartis Vaccines and Diagnostics S.r.l. | Immunisierung gegen chlamydia pneumoniae |
-
1999
- 1999-10-29 US US09/430,723 patent/US6607730B1/en not_active Expired - Fee Related
- 1999-11-02 EP EP99954126A patent/EP1127065B1/de not_active Expired - Lifetime
- 1999-11-02 AU AU10565/00A patent/AU753984B2/en not_active Ceased
- 1999-11-02 DE DE69940268T patent/DE69940268D1/de not_active Expired - Fee Related
- 1999-11-02 CA CA002349504A patent/CA2349504A1/en not_active Abandoned
- 1999-11-02 NZ NZ511889A patent/NZ511889A/en not_active IP Right Cessation
- 1999-11-02 WO PCT/GB1999/003622 patent/WO2000026239A2/en active IP Right Grant
- 1999-11-02 JP JP2000579626A patent/JP2002530054A/ja active Pending
- 1999-11-02 AT AT99954126T patent/ATE420106T1/de not_active IP Right Cessation
-
2003
- 2003-01-28 US US10/352,618 patent/US20040022801A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20040022801A1 (en) | 2004-02-05 |
| AU1056500A (en) | 2000-05-22 |
| CA2349504A1 (en) | 2000-05-11 |
| WO2000026239A3 (en) | 2000-08-10 |
| EP1127065B1 (de) | 2009-01-07 |
| JP2002530054A (ja) | 2002-09-17 |
| EP1127065A2 (de) | 2001-08-29 |
| AU753984B2 (en) | 2002-10-31 |
| NZ511889A (en) | 2003-12-19 |
| WO2000026239A2 (en) | 2000-05-11 |
| US6607730B1 (en) | 2003-08-19 |
| DE69940268D1 (de) | 2009-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2002074979A3 (en) | Expression profiles and methods of use | |
| HUP0402271A2 (hu) | Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek | |
| WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
| AR062019A1 (es) | Gen de bacillus thuringiensis con actividad contra lepidopteros | |
| DE69634412D1 (de) | Regulierte gene und ihre verwendungen | |
| AR047347A1 (es) | Miembros de la familia cry9 de bacillus | |
| KR920700228A (ko) | 단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법) | |
| BR9913360B1 (pt) | proteÍna de uricase recombinante quimÉrica, molÉcula de Ácido nuclÉico isolada e purificada, vetor e cÉlula hospedeira transformada. | |
| ATE211174T1 (de) | Thymidin-kinase-mutanten | |
| RS92704A (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
| WO2002040668A3 (de) | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen | |
| DK0981631T3 (da) | Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme | |
| WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
| DE60041042D1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| ATE420106T1 (de) | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung | |
| MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01001639A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| CA2628354A1 (en) | Organic cation transporter genes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |